Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2013
11/06/2013CN101835892B CDCA1 peptide and pharmaceutical agent comprising the same
11/06/2013CN101678213B Cyclic peptide cxcr4 antagonists
11/06/2013CN101641371B 肽及其用途 Peptides and their uses
11/06/2013CN101448851B Improved antimicrobial peptides
11/05/2013US8575309 Delta-opioid receptor selective analgesics
11/05/2013US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
11/05/2013US8575111 Pharmaceutical compositions and methods for treating erectile dysfunction
11/05/2013US8575103 Peptides and methods for inhibiting G alpha protein signaling
11/05/2013US8575094 Use of type-B lantibiotic-based compounds having antimicrobial activity
11/05/2013US8574586 KDR peptides and vaccines comprising the same
11/05/2013US8574585 KDR peptides and vaccines comprising the same
11/05/2013CA2558050C Methods and compositions for the treatment of gastrointestinal disorders
10/2013
10/31/2013WO2013163423A1 Compositions and methods for wound healing and tissue repair
10/31/2013WO2013163248A1 Par4 agonist peptides
10/31/2013WO2013159422A1 Small molecular peptide and use thereof
10/31/2013WO2013111110A3 Synthetic apelin mimetics for the treatment of heart failure
10/31/2013WO2012130999A9 Peptides isolated and purified from fruit bat testicles
10/31/2013WO2002069885A9 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
10/31/2013US20130289238 Par4 agonist peptides
10/31/2013US20130288987 Melanocortin Receptor-Specific Peptides for Treatment of Female Sexual Dysfunction
10/31/2013US20130288980 Targeting senescent and cancer cells for selective killing by interference with foxo4
10/31/2013US20130288974 Method for ameliorating pain by modification of nmda receptors through inhibition of src
10/31/2013US20130288961 Methods for treating steatotic disease
10/31/2013US20130288363 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
10/31/2013US20130287807 Compounds for treating symptoms associated with parkinson's disease
10/30/2013EP2657338A1 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
10/30/2013EP2655400A1 Factor h binding peptides and uses thereof
10/30/2013EP2654778A1 Vaccines based on peptides of the complement protein c5a
10/30/2013EP2654768A1 Peptides for treating cancer
10/30/2013CN103379913A Peptides for treating cancer
10/30/2013CN103379912A N-carboxyalkyl auristatins and the use thereof
10/30/2013CN103379911A PGC-1[alpha]-modulating peptides
10/30/2013CN103376326A Application of vitamin D binding protein as obesity-diabetes marker
10/30/2013CN103376325A Application of angiotensinogen protein precursor as obesity-diabetes marker
10/30/2013CN103376324A Application of albumin as obesity-diabetes marker
10/30/2013CN103376323A Application of apolipoprotein C-III as marker of obesity-diabetes
10/30/2013CN103376322A Application of apolipoprotein B 100 as marker of obesity-diabetes
10/30/2013CN103374058A Solid-phase synthesis process of angiotensinamide as well as intermediate and application thereof
10/30/2013CN103372198A Polypeptide suppressant for suppressing virus
10/30/2013CN102775471B Method for synthesizing cholecystokinin octapeptide by combining solid phase method and liquid phase method
10/30/2013CN102702327B Solid-liquid phase synthesis method for alarelin acetate
10/30/2013CN101801995B Antibiotic peptides
10/30/2013CN101408546B Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assaykit
10/29/2013US8569449 Synthetic peptides and peptide mimetics
10/29/2013US8569446 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/29/2013US8569243 Sirtuin 6 activating peptides and cosmetic or pharmaceutical composition containing them
10/29/2013US8569234 Compositions and methods for including melanogenesis in a subject
10/29/2013US8569230 Antimicrobial kinocidin compositions and methods of use
10/29/2013US8569005 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
10/29/2013US8568973 Cell-signaling assays
10/29/2013US8568781 Peptide-carrying nanoparticles
10/29/2013US8568732 Chlamydia antigens
10/29/2013CA2662876C Michael systems as transglutaminase inhibitors
10/29/2013CA2469134C Novel peptide and pharmaceutical use of the same
10/24/2013WO2013158959A1 Compositions and methods for treatment of graft-versus-host disease
10/24/2013WO2013158841A1 Peptide mimotopes to oxidation specific epitopes
10/24/2013WO2013158600A1 Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
10/24/2013WO2013157410A1 Fzd10-binding peptide
10/24/2013WO2013156493A1 Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/24/2013WO2013091883A3 Selective ligands for the angiotensin ii receptors
10/24/2013WO2012140500A9 Selective cysteine protease inhibitors and uses thereof
10/24/2013WO2010079063A3 Modulators of the cx3cr1 receptor and therapeutic uses thereof
10/24/2013WO2008083493A8 Stabilization of cyclic peptide structures
10/24/2013WO2002061044A9 Synthetic peptide and uses for same
10/24/2013US20130281662 Process for the manufacture of degarelix and its intermediates
10/24/2013US20130281661 Process for the manufacture of degarelix and its intermediates
10/24/2013US20130281660 Detection of degradative anzymes and biomolecules in bodily fluids
10/24/2013US20130281657 Macrocycles and macrocycle stabilized peptides
10/24/2013US20130281384 Larazotide acetate compositions
10/24/2013US20130281360 Broad spectrum antibiotic arylomycin analogs
10/24/2013US20130281309 Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker
10/24/2013US20130280760 High purity lipopetides
10/24/2013US20130280281 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
10/23/2013EP2652512A2 Use of ide as a biomarker for a scalp condition
10/23/2013EP2651965A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
10/23/2013EP2651964A2 Croos-linked peptides and proteins, methods of making same, and uses thereof
10/23/2013EP2651963A1 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/23/2013EP2651429A2 Neuropeptide analogs, compositions, and methods for treating pain
10/23/2013EP2651428A1 Pgc-1alpha-modulating peptides
10/23/2013CN103370089A Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same
10/23/2013CN103360469A 抗微生物多肽 Antimicrobial peptides
10/23/2013CN103360468A Preparation method for SCD1 polypeptide and anti-goose SCD1 polypeptide polyclonal antibody
10/23/2013CN103360467A Preparation method of broad-spectrum antibacterial polypeptide
10/23/2013CN103360466A Composition of tumour-associated peptides and related anti-cancer vaccine
10/23/2013CN103360465A HLA-A*0201 restricted CTL epitope of cytoplasmic polyadenylation element binding proteins (CPEBs) 4 and application thereof
10/23/2013CN103360464A Polypeptide, DNA molecule encoding polypeptide, vector, preparation method and application thereof
10/23/2013CN102807607B Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
10/23/2013CN101868245B Synthetic peptide containing bone forming peptide 1(BFP 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising synthetic peptide
10/22/2013US8566072 Cyclin based inhibitors of CDK2 and CDK4
10/22/2013US8563688 Procoagulant peptides
10/22/2013US8563682 Guanylylcyclase C ligands
10/22/2013US8563515 Tight junction protein modulators and uses thereof
10/22/2013US8563514 Peptides and pharmaceutical compositions for treating connective tissue
10/22/2013US8563000 Melanocortin receptor ligands modified with hydantoin
10/22/2013CA2657338C Anti-inflammatory and antiallergic cyclic peptides
10/22/2013CA2405035C Improved method for the production of bacterial toxins
10/17/2013WO2013155360A1 A method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation
10/17/2013WO2013154208A1 Method for identifying and quantifying types of animal hair
10/17/2013WO2013153196A1 Compounds which inhibit neuronal exocytosis
10/17/2013WO2013153192A1 Compounds which inhibit neuronal exocytosis (iii)
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 423